Our observation of lower expression levels of irisin in breast cancer is supported by the findings of Gannon et al. evaluating the effect of various concentrations of irisin on the behavior of malignant and non-malignant breast epithelial cell lines [44]. Here, FNDC5 is linked to breast carcinoma.